JMP Securities analyst Jason Butler reiterated a Buy rating on Syros Pharmaceuticals (SYRS – Research Report) today and set a price target of $20.00. The company's shares closed last Monday at $3.32, close to its 52-week low of $3.30. According to TipRanks.com, Butler is a 2-star analyst with an average return of 0.5% and a 42.6% success rate. Butler covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Aquestive Therapeutics, and ACADIA Pharmaceuticals. Syros Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $19.33, which is a 455.5% upside from current levels.
https://www.tipranks.com/news/blurbs/jmp-securities-thinks-syros-pharmaceuticals-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral